TMPRSS-12 (Recombinant)

Recombinant Protein · expressed in HEK293
Citation tracking pending
Recombinant human TMPRSS-12 (UniProt Q86WS5), expressed in HEK293 cells. A type II transmembrane serine protease studied for roles in sperm capacitation, male fertility, and ectopic gene expression in cancer contexts.
Expression system
HEK293
Cat. #
REC-TMPRSS12

In stock

SKU
REC-TMPRSS12
$498.00

Target Overview

TMPRSS-12 (Transmembrane Protease Serine 12; UniProt Q86WS5) is a 348-amino acid type II transmembrane serine protease encoded by the TMPRSS12 gene. It belongs to the TMPRSS family of cell-surface serine endopeptidases (EC 3.4.21.-) characterised by an extracellular serine protease catalytic domain, a transmembrane anchor, and a short cytoplasmic tail. This recombinant form is produced in HEK293 mammalian cells, providing authentic post-translational modifications — including glycosylation patterns relevant to this membrane-tethered protease — that may be absent from prokaryotic or insect-cell expression systems. TMPRSS-12 is predominantly expressed in the testis, where it localises to the cell membrane of developing and mature spermatogenic cells. Published functional studies have established roles in sperm capacitation, acrosome reaction, and zona pellucida binding, and indicate that the protease supports normal spermatogenesis partly through regulation of ADAM3 maturation. In the laboratory, this recombinant is suited for several experimental contexts. Researchers use it as a positive control antigen in Western blot and immunohistochemistry antibody validation — it pairs directly with the Triple Point Biologics matched antibody (SKU: RP-TMPRSS12), available on this site. It is also used as a defined substrate source for identifying serine protease cleavage targets by mass spectrometry-based proteomics, and as a reference enzyme in inhibitor profiling assays using fluorogenic peptide substrates. Additionally, its ectopic expression profile in certain cancer tissues (see Background below) has prompted its use as a recombinant standard in expression-level comparisons and epigenetic regulation studies conducted in vitro.

Background

TMPRSS-12 belongs to the type II transmembrane serine protease (TTSP) subfamily, a group of membrane-anchored endopeptidases that regulate pericellular proteolysis across multiple tissue compartments. Within the testis, TMPRSS-12 has been characterised as a functionally non-redundant component of the male germline proteolytic network. Zhang et al. (2022, PMID: 35547804) demonstrated in a mouse knockout model that Tmprss12 is required for meiosis and spermiogenesis: male mice lacking the gene are infertile, exhibiting defects in chromosomal synapsis, double-strand break repair, inner mitochondrial membrane cristae formation, and regulated apoptosis during spermatogenesis. Sperm from knockout animals showed markedly reduced motility and failure to bind the zona pellucida, consistent with impaired ADAM3 maturation — a metalloprotease whose cell-surface processing depends on the broader TMPRSS family proteolytic environment. These findings position TMPRSS-12 as a research target in the mechanistic study of male infertility and a potential subject of male contraceptive research, a field now supported by complementary transgenic models for related testicular serine proteases (Sutton et al., 2025, PMID: 40764777). Beyond the testis, TMPRSS-12 has been identified as a gene whose expression profile is altered in colon cancer tissue relative to normal mucosa. Almutairi et al. (2024, PMID: 39208330) examined TMPRSS12 alongside a panel of testis-enriched genes — including TEX101, SYCP1, and SYCE1 — in colon cancer specimens and cell lines, and reported differential expression and in vitro responsiveness to epigenetic drugs. This places TMPRSS-12 in the broader category of cancer-testis genes, a class studied as research targets for tumour biology and as candidate biomarkers, given their restricted normal-tissue expression. The recombinant protein supports in vitro experiments characterising such expression changes, including ELISA-based quantification, cell-free activity comparisons, and epigenetic modulation readouts. TMPRSS-12 also sits within the wider TMPRSS family context relevant to viral entry research; while TMPRSS2 has received the most attention as a SARS-CoV-2 co-factor, the overlapping expression of TMPRSS family members in reproductive tissues remains an active area of basic research inquiry (Aitken, 2021, PMID: 32649023). Researchers investigating serine protease cross-reactivity, substrate overlap, or inhibitor selectivity across TMPRSS family members will find this recombinant useful as a specificity control or comparator in panel-based assays. Researchers requiring an orthogonal detection tool alongside this recombinant for antibody validation workflows can pair it with the Triple Point Biologics TMPRSS-12 antibody (SKU: RP-TMPRSS12), validated for Western blot against human targets.

Applications

  • Serine protease activity assay using fluorogenic peptide substrates (e.g., AMC-conjugated substrates) to confirm catalytic competency of the recombinant preparation
  • Inhibitor IC50 determination for small-molecule or peptide-based serine protease inhibitors in biochemical screening formats
  • Antibody validation positive control — co-run with Triple Point Biologics anti-TMPRSS-12 antibody (RP-TMPRSS12) in Western blot to confirm band identity at expected molecular weight
  • Immunohistochemistry (IHC) standard — recombinant used to calibrate antibody titration and signal intensity before application to tissue sections
  • Substrate identification by mass spectrometry — incubation of recombinant TMPRSS-12 with candidate substrate proteins followed by LC-MS/MS peptide mapping to define cleavage site specificity
  • TMPRSS-family selectivity profiling — included as a panel member alongside TMPRSS2 and related recombinants to assess inhibitor or antibody cross-reactivity across family members
  • ELISA capture or detection standard for quantifying TMPRSS-12 levels in biological samples or conditioned media from epigenetic drug treatment experiments

References

  1. Zhang J et al. TMPRSS12 Functions in Meiosis and Spermiogenesis and Is Required for Male Fertility in Mice. Front Cell Dev Biol. 2022. doi:10.3389/fcell.2022.757042 PMID: 35547804
  2. Almutairi MH et al. Differential expression and regulation of ADAD1, DMRTC2, PRSS54, SYCE1, SYCP1, TEX101, TEX48, and TMPRSS12 gene profiles in colon cancer tissues and their in vitro response to epigenetic drugs. PLoS One. 2024. doi:10.1371/journal.pone.0307724 PMID: 39208330
  3. Sutton CM et al. Rescue of male infertility by human PRSS55 in transgenic mice establishes a contraceptive research model. Sci Rep. 2025. doi:10.1038/s41598-025-09604-9 PMID: 40764777
  4. Aitken RJ. COVID-19 and human spermatozoa-Potential risks for infertility and sexual transmission? Andrology. 2021. doi:10.1111/andr.12859 PMID: 32649023
  5. Akhtar S et al. PRSS23 promotes ovarian cancer peritoneal dissemination independent of protease activity. J Biol Chem. 2026. doi:10.1016/j.jbc.2026.111450 PMID: 41985786

Additional Specifications

Storage Buffer 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol
Endotoxin Level <0.1 EU/µg by LAL
Purity (%) >90% by SDS-PAGE
Expression System HEK293
Subcellular Localization Type II transmembrane serine protease; cell surface

Frequently Asked Questions

What molecular weight band should I expect for recombinant TMPRSS-12 on SDS-PAGE or Western blot?

The predicted molecular weight of TMPRSS-12 (Q86WS5) based on its 348-amino acid sequence is approximately 39 kDa. However, because this recombinant is produced in HEK293 mammalian cells, N-linked and O-linked glycosylation will shift the apparent molecular weight on SDS-PAGE to roughly 45–55 kDa under reducing conditions. The exact migration can vary slightly with gel percentage; we recommend a 10–12% polyacrylamide gel for clean resolution in this range. Under non-reducing conditions, expect a modestly higher apparent MW due to intramolecular disulfide architecture.

Is recombinant TMPRSS-12 full-length or a processed catalytic domain fragment?

This recombinant form (REC-TMPRSS12) encompasses the extracellular serine protease catalytic domain of TMPRSS-12, which is the enzymatically active region relevant to substrate cleavage and protein interaction studies. It does not include the single-pass transmembrane anchor or the short cytoplasmic tail present in the native type II transmembrane topology. This design yields a soluble, active protein suitable for biochemical assays, while still recapitulating authentic glycosylation patterns that prokaryotic or insect-cell systems would not provide.

What substrates does TMPRSS-12 cleave and which synthetic peptide substrate should I use in an activity assay?

TMPRSS-12 is a trypsin-like serine endopeptidase (EC 3.4.21.-) that cleaves after basic residues (Arg, Lys). For fluorogenic activity assays, Boc-Gln-Ala-Arg-AMC and Tos-Gly-Pro-Arg-AMC are commonly used substrates for type II transmembrane serine proteases in this family and are a reasonable starting point. In published biological contexts, TMPRSS-12 has been implicated in ADAM3 maturation on the sperm surface. Confirm substrate preference empirically with your specific lot by titrating substrate concentration from 50–500 µM and monitoring fluorescence release (Ex 360 nm / Em 460 nm) over 30–60 minutes at 37°C.

What assay buffer and conditions work best for TMPRSS-12 protease activity assays?

The storage buffer — 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol — is compatible with direct use in activity assays and requires no buffer exchange for most applications. For optimal serine protease activity, a working assay buffer of 50 mM Tris-HCl pH 8.0, 100–150 mM NaCl, 0.01% Tween-20 is a good starting formulation. TMPRSS-12 is a serine protease, so avoid PMSF or other serine protease inhibitors in your assay. Conduct reactions at 37°C; BSA at 0.1 mg/mL can be added to stabilize the enzyme at low concentrations (< 50 nM).

What starting concentration of recombinant TMPRSS-12 should I use in a biochemical protease activity assay?

A practical starting point is 10–50 nM of REC-TMPRSS12 per reaction with a fluorogenic substrate at 100–200 µM. Titrate enzyme concentration to identify the linear range of product formation, typically within the first 15–30 minutes before substrate depletion. For inhibitor IC50 determinations, fix the enzyme at the lowest concentration giving a robust signal (often 10–20 nM) and titrate inhibitor across at least 8 concentrations spanning 3 log units. Ensure total DMSO from inhibitor stocks does not exceed 1% (v/v) in the final reaction volume to avoid serine protease inhibition artifacts.

Can I use REC-TMPRSS12 as a positive control for Western blot with the matched RP-TMPRSS12 rabbit polyclonal antibody?

Yes — this is one of the primary intended uses of REC-TMPRSS12 alongside RP-TMPRSS12 (/anti-tmprss-12-rabbit-polyclonal-antibody). The recombinant protein and the antibody are produced and validated in the same laboratory, ensuring antigen-antibody compatibility. Load 50–200 ng of REC-TMPRSS12 per lane on a reducing SDS-PAGE gel alongside your experimental lysates. You should detect a band at approximately 45–55 kDa under these conditions with RP-TMPRSS12 at a 1:500–1:2000 dilution. This positive control lane also allows you to confirm antibody specificity and lot-to-lot consistency in your hands.

How much recombinant TMPRSS-12 should I load for a Western blot positive control lane?

Load 50–200 ng per lane as a starting range when using RP-TMPRSS12 for detection. Begin at 100 ng if your chemiluminescence substrate is standard-sensitivity HRP; drop to 50 ng if using high-sensitivity ECL to avoid signal saturation. Run on a 10–12% SDS-PAGE gel under reducing conditions. The glycosylated recombinant will migrate at ~45–55 kDa, distinctly separated from most common housekeeping proteins. If you are establishing the assay for the first time, run a 3-point titration (50, 100, 200 ng) in parallel with your cell lysate to bracket the optimal loading amount.

How should I handle, dilute, and store recombinant TMPRSS-12 to preserve activity?

REC-TMPRSS12 is supplied in 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol as single-use aliquots. Store at -20°C upon receipt; avoid repeated freeze-thaw cycles, which progressively denature serine proteases. Thaw aliquots on ice and use within the same working session. For dilutions below 100 nM, use assay buffer supplemented with 0.1 mg/mL BSA as carrier to minimize adsorptive losses to tube walls. Purity is >90% by SDS-PAGE and endotoxin is <0.1 EU/µg by LAL, so no additional clean-up is needed for standard biochemical or cell-based assays.

Validation imagery coming soon

Western blot validation figures for REC-TMPRSS12 will be published here as they are produced in-house.

If you would like to see existing validation data for this antibody before publication, request a sample copy.

  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →